Eye on A.I.
Anthropic's IPO Play, Novo Nordisk X OpenAI, and the First Brain Sensor Goes Human
Why It Matters
These stories illustrate how AI is reshaping consumer tech, cloud infrastructure, and financial security, while also intensifying public and political scrutiny of AI pioneers. Understanding these trends helps listeners gauge where industry momentum is heading and why the personal safety of AI executives is becoming a new frontier in the tech landscape.
Key Takeaways
- •Apple testing non‑AR smart glasses for 2027 launch
- •Vercel’s revenue jump fuels IPO; AI agents power 30% apps
- •Anthropic bans OpenClaw creator after pricing shift to API
- •US banks urged to trial Anthropic’s Mythos for vulnerability detection
- •Sam Altman survives Molotov attack, admits personal flaws publicly
Pulse Analysis
Apple is quietly prototyping four frame styles for a new line of smart glasses that will launch around 2027, according to Bloomberg’s Mark Gurman. Unlike the Vision Pro, these devices won’t feature heads‑up AR overlays; they focus on core functions such as photo and video capture, calls, music playback, and integration with Apple’s upgraded AI assistant. By opting for a simpler, camera‑centric design in colors like black, blue, and light brown, Apple appears to be hedging against the mixed‑reality flop of its previous headset while positioning itself against Meta’s Ray‑Ban collaboration and Google’s longer‑term AR ambitions.
Vercel’s CEO Guillaume Rauch highlighted a revenue surge from $100 million to a $340 million run‑rate, signaling the company’s readiness for an IPO. The growth is driven by AI agents now generating roughly 30 % of the apps hosted on Vercel, a trend the host attributes to seamless integration with tools like CloudCode. Meanwhile, Anthropic sparked controversy by temporarily banning OpenClaw creator Peter Steinberger after changing its pricing model, forcing third‑party tools to use direct API billing instead of the subsidized Claude subscription. This move underscores the tension between open‑source developers and proprietary AI platforms seeking sustainable revenue.
In a parallel development, the U.S. Treasury and Federal Reserve encouraged major banks—including JPMorgan, Goldman Sachs, and Bank of America—to pilot Anthropic’s Mythos model for detecting security vulnerabilities, despite ongoing legal disputes over the model’s military use. Across the Atlantic, UK regulators are also weighing Mythos’s risk profile. The episode also covered the dramatic Molotov‑cocktail attack on Sam Altman’s San Francisco home and his candid blog response, acknowledging personal flaws and emphasizing broader industry responsibility. Altman’s experience highlights the escalating personal and political risks faced by AI leaders as public scrutiny intensifies.
Episode Description
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI land grab means for the industry. Plus, Science Corp (founded by ex-Neuralink co-founder Max Hodak) is preparing to place its first sensor in a human brain, Stanford's latest AI Index reveals a growing disconnect between AI insiders and the public, and Google rolls out AI Skills in Chrome so you can save and reuse your favorite workflows.
Get the top 80+ AI Models for $8.99 at AI Box: https://aibox.ai
How I Grow and Scale My Business with AI: https://www.skool.com/aihustle
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Comments
Want to join the conversation?
Loading comments...